Position-5-Driven Reorientation of an Immunodominant HLA-A*24:02 SARS-CoV-2 Epitope Drives Universal T-cell Escape
Cytotoxic T lymphocytes form a critical component of SARS-CoV-2 immunity by recognizing viral peptides bound to HLA class I molecules. Here, we identified the Spike-derived peptide NYNYLYRLF448-456 (NF9) as the immunodominant HLA-A*24:02-restricted epitope in both convalescent and vaccinated donors. Across cohorts, A24/NF9-specific responses were dominated by public TCR motifs featuring TRAV12-1 (or TRAV6-1) paired with TRBJ2-7 and a conserved CDR3β sequence (CASSXXXGYEQYF). Using a panel of thirteen TCRs, we mapped recognition of single amino acid substitutions within NF9 and identified residue 5 (L452) as the principal determinant of escape. The L452R substitution, characteristic of the Delta variant, abolished recognition across all tested TCRs despite preserved HLA binding. Crystallography of a representative public TCR (P1-15) revealed that mutation at position 5 reoriented the peptide within HLA-A*24:02, flipping the adjacent Y453 side chain into the peptide-binding groove and eliminating the dominant TCR contact. This position-5-driven conformational switch provided a structural mechanism for universal loss of NF9 recognition by HLA-A*24:02-restricted T-cells. Consistent with this, Delta-infected convalescents failed to mount de novo NF9-5R-specific responses while retaining responses to the conserved A24/QI9 Spike epitope. Together, these findings defined the basis of A24/NF9 recognition and showed how one mutation remodelled peptide presentation to abrogate TCR responses.
Authors
- Aaron Wall
- Andrew Kelvin Sewell (ORCID: https://orcid.org/0000-0003-3194-3135)
- Hiroshi Hamana (ORCID: https://orcid.org/0000-0002-6964-1020)
- Hirotomo Nakata (ORCID: https://orcid.org/0000-0002-7333-2327)
- P.J. Rizkallah (ORCID: https://orcid.org/0000-0002-9290-0369)
- Mako Toyoda
- Hiroyuki Kishi (ORCID: https://orcid.org/0000-0002-8740-5371)
- Yoshiki Aritsu
- Huanyu Li (ORCID: https://orcid.org/0000-0002-5482-9936)
- Yusuke Miyashita (ORCID: https://orcid.org/0000-0002-4696-6834)
- Hiroyuki Oshiumi (ORCID: https://orcid.org/0000-0003-1567-8722)
- Garry Dolton (ORCID: https://orcid.org/0000-0002-6332-9108)
- Mizuki Kitamatsu (ORCID: https://orcid.org/0000-0001-8643-8238)
- Toong Seng Tan (ORCID: https://orcid.org/0000-0002-6751-5987)
- Takamasa Ueno (ORCID: https://orcid.org/0000-0003-4852-4236)
- Yoshihiko Goto
- Keiko Udaka
- Yoji Nagasaki
- Chihiro Motozono
- Li-Rong Tan
- Rumi Minami
- Takeshi Nakama
- Hannah Thomas
- Kimitoshi Nakamura
Institutions
- Kumamoto Health Science University (JP)
- University of Kochi (JP)
- National Kyushu Medical Center (JP)
- Kumamoto University Hospital (JP)
- University of Toyama (JP)
- Kōchi University (JP)
- Cardiff University (GB)
- Kindai University (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- JCI Insight
- Published
- 2026-03-17
- DOI
- https://doi.org/10.1172/jci.insight.202235
- Primary Topic
- vaccines and immunoinformatics approaches
- Type
- article
- Field-Weighted Citation Impact
- 0.00